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Introduction
Early studies performed in sea urchin eggs showed that wounded 
eukaryotic cells rapidly repair their plasma membrane by a pro-
cess dependent on extracellular Ca
2+ (Heilbrunn, 1956; Chambers 
and  Chambers,  1961).  However,  insights  into  the  cellular 
mechanism underlying this process were only obtained several 
decades later, when a functional link was established between 
plasma membrane repair and the delivery of intracellular mem-
brane to the cell surface by exocytosis (Bi et al., 1995; Miyake 
and McNeil, 1995). This Ca
2+-dependent, exocytosis-mediated 
resealing process occurs <30 s after plasma membrane injury 
(Steinhardt et al., 1994) and involves the fusion of lysosomal 
organelles with the plasma membrane (Rodríguez et al., 1997; 
Reddy et al., 2001; Jaiswal et al., 2002). Based on these initial 
findings, two models were proposed for exocytosis-mediated 
plasma membrane repair. The first model postulated that Ca
2+ 
influx triggers homotypic fusion of intracellular vesicles, form-
ing a patch that directly fuses with the wounded membrane site 
(McNeil et al., 2000). The second model proposed that resealing 
of the lipid bilayer is facilitated by reduction in plasma mem-
brane tension, a consequence of Ca
2+-triggered exocytosis (Togo 
et al., 1999).
However, these two models fail to explain the observation 
that stable lesions caused by pore-forming toxins are also re-
moved from the plasma membrane in a Ca
2+-dependent manner 
(Walev et al., 2001). A recent investigation of this issue revealed 
that Ca
2+ influx into wounded cells triggers not only lysosomal 
exocytosis but also a novel form of endocytosis (Idone et al., 
2008b). This unusual form of endocytosis, which occurs within 
R
apid  plasma  membrane  resealing  is  essential  for 
cellular survival. Earlier studies showed that plasma 
membrane repair requires Ca
2+-dependent exo-
cytosis of lysosomes and a rapid form of endocytosis that   
removes membrane lesions. However, the functional rela-
tionship between lysosomal exocytosis and the rapid endo-
cytosis that follows membrane injury is unknown. In this 
study, we show that the lysosomal enzyme acid sphingo-
myelinase (ASM) is released extracellularly when cells are 
wounded in the presence of Ca
2+. ASM-deficient cells, in-
cluding human cells from Niemann-Pick type A (NPA) 
patients, undergo lysosomal exocytosis after wounding but 
are defective in injury-dependent endocytosis and plasma 
membrane repair. Exogenously added recombinant human 
ASM restores endocytosis and resealing in ASM-depleted 
cells, suggesting that conversion of plasma membrane 
sphingomyelin to ceramide by this lysosomal enzyme pro-
motes lesion internalization. These findings reveal a molec-
ular mechanism for restoration of plasma membrane 
integrity through exocytosis of lysosomes and identify de-
fective plasma membrane repair as a possible component 
of the severe pathology observed in NPA patients.
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the molecular mechanism responsible for this novel form of 
endocytosis. The large, uncoated peripheral endosomes observed 
in wounded cells strongly resembled the vesicles formed in J774 
macrophages after exposure to bacterial sphingomyelinase (Zha 
et al., 1998). In that study, it was suggested that sphingomyelinase-
mediated changes in lipid composition might have created 
bilayer asymmetries favoring membrane bending and endosome 
formation (Zha et al., 1998). Subsequent studies confirmed 
that ceramide, a sphingolipid generated by hydrolytic removal 
of the phosphorylcholine head group of sphingomyelin by 
sphingomyelinase, coalesces in membranes to form large do-
mains that are capable of inward budding (Holopainen et al., 
2000; Gulbins and Kolesnick, 2003; van Blitterswijk et al., 
2003; Grassmé et al., 2007). These findings prompted us to 
seconds of plasma membrane injury, is dynamin independent, 
facilitated by disruption of the cortical actin cytoskeleton, and 
capable of internalizing transmembrane pores. Interestingly, this 
Ca
2+-dependent form of endocytosis is also observed in mechani-
cally injured cells. This finding, together with the very similar ki-
netics of plasma membrane resealing observed in cells injured 
mechanically or by pore-forming toxins, led to the proposal of a 
new general model for plasma membrane repair (Idone et al., 
2008a,b). This model postulates that the exocytosis of lysosomes 
triggered by Ca
2+ entry through membrane wounds is immediately 
followed by endocytosis, which mediates lesion internalization 
and restoration of plasma membrane integrity.
Examination of the morphology of injury-induced endo-
somes (Idone et al., 2008b) provided an unexpected insight into 
Figure 1.  Inhibition of lysosomal exocytosis 
in injured cells results in defective endocytosis 
and  plasma  membrane  repair.  (A)  -Hexos-
aminidase (Hex) secretion from nontreated (NT) 
or BEL-treated NRK cells after SLO exposure 
with or without Ca
2+. Error bars represent SD. 
(B) Nontreated or BEL-treated cells processed 
for EM 4 min after exposure to SLO/Ca
2+ and 
BSA-gold. Short arrows point to BSA-gold parti-
cles within endosomes in nontreated cells (NT); 
long arrows point to swollen ER compartments 
in  BEL-treated  cells  (BEL).  M,  mitochondria. 
(right) EM quantification. The data represent 
the mean ± SD (**, P < 0.0001; unpaired Stu-
dent’s t test). (C) FACS quantification of WGA-
FITC endocytosis after exposure to SLO/Ca
2+ 
in  nontreated  or  BEL-treated  cells.  (D)  FACS 
quantification of PI staining in nontreated or 
BEL-treated  cells  permeabilized  with  SLO. 
Without Ca
2+ (middle), both groups of cells re-
mained permeabilized; with Ca
2+, nontreated 
cells resealed their membrane more efficiently, 
excluding PI (right). (E) FACS quantification of 
PI staining in nontreated or BEL-treated cells 
after scrape wounding. Cells treated or not with 
BEL were similarly wounded, as indicated by 
the uptake of PI added during scraping (left). 
PI added 4 min after scraping revealed that 
both groups remained permeabilized without 
Ca
2+ (middle), but with Ca
2+, nontreated cells 
resealed their membrane more efficiently, ex-
cluding PI (right). Percentages correspond to 
resealed (PI negative) cells in the gated region 
(dashed lines). The results shown in this figure 
are representative of several independent ex-
periments. Bars, 250 nm.1029 Lysosomal sphingomyelinase mediates cell resealing • Tam et al.
during cell injury, gaining access to the outer leaflet of the 
plasma membrane.
The ASM inhibitor desipramine (DPA)  
does not impair lysosomal exocytosis  
but inhibits endocytosis and plasma 
membrane repair
The exocytosis of active ASM during injury-induced lysosomal 
exocytosis was consistent with a role for this lysosomal enzyme 
in the generation of ceramide domains in the plasma membrane, 
a process which can promote inward budding and vesicle forma-
tion (Holopainen et al., 2000; Gulbins and Kolesnick, 2003).   
To investigate whether ASM activity was required for endocytosis 
and plasma membrane repair, we first tested the effect of a potent 
ASM inhibitor, DPA (Kölzer et al., 2004). DPA-treated normal 
rat kidney (NRK) cells showed a significant reduction (95%) in 
total ASM activity (Fig. 3 A) but remained capable of vigorous 
exocytosis of lysosomes upon exposure to SLO in the pres-
ence of Ca
2+ (Fig. 3 B). In contrast, the number of recently formed 
endosomes in wounded cells was reduced 50% by DPA, as 
determined by EM quantification (Fig. 3 C) and WGA-FITC 
quench-protection endocytosis assays (Fig. 3 D). DPA treatment 
inhibited injury-induced endocytosis in cells wounded by either 
SLO permeabilization or by scraping from the dish (Fig. 3 D). 
Consistent with the key role of injury-induced endocytosis in 
plasma membrane repair (Idone et al., 2008a,b), the kinetics of 
SLO pore removal and plasma membrane resealing were delayed 
in DPA-treated cells. DPA treatment markedly increased influx of 
the lipophilic dye FM1-43 in the presence of Ca
2+ when com-
pared with nontreated cells. Although FM1-43 staining was 
mostly restricted to the plasma membrane in nontreated wounded 
cells, after DPA treatment, the dye was able to enter cells and 
investigate whether the ceramide-generating lysosomal enzyme 
acid sphingomyelinase (ASM; Schuchman et al., 1991) plays a 
role in the endocytic process that mediates plasma membrane 
repair (Idone et al., 2008b).
Results
Blocking lysosomal exocytosis inhibits 
endocytosis and plasma membrane resealing
Lysosomal exocytosis is partially reduced in cells deficient in fac-
tors regulating exocytosis such as synaptotagmin VII and the   
v-SNARE VAMP7 (Chakrabarti et al., 2003; Rao et al., 2004), 
whereas complete inhibition is achieved by removing Ca
2+ from 
the extracellular medium (Rodríguez et al., 1997). Because plasma 
membrane repair is also strongly dependent on extracellular 
Ca
2+, we searched for a method to block lysosomal exocytosis 
without interfering with Ca
2+ influx. We found that bromoenol 
lactone (BEL; Fensome-Green et al., 2007) strongly inhibited the 
extracellular accumulation of lysosomal -hexosaminidase when 
cells were wounded by exposure to the bacterial pore-forming 
toxin streptolysin O (SLO; Fig. 1 A). To determine the effect of 
BEL treatment on endocytosis, we quantified by EM the number 
of intracellular vesicles containing the fluid phase tracer BSA-
gold 4 min after SLO injury. The number of newly formed endo-
somes was reduced 10-fold in BEL-treated cells (Fig. 1 B), and 
inhibition was also seen with a quantitative quench-protection 
endocytosis assay. In this assay, reduction in fluorescence inten-
sity reflects accumulation of WGA-FITC on the plasma mem-
brane because of susceptibility of the WGA-FITC to quenching 
by membrane-impermeable trypan blue (Fig. 1 C; Idone et al., 
2008b). The EM morphology of BEL-treated cells exposed to 
SLO (swollen ER compartments and less dense cytoplasm) sug-
gested a defect in plasma membrane repair. Flow cytometric de-
tection of the membrane impermeant dye propidium iodide (PI) 
showed that BEL, while not interfering with the susceptibility of 
cells to SLO permeabilization or scrape wounding (Fig.1, D and E, 
Mg
2+), abrogated the ability of these cells to reseal efficiently 
after injury (Fig. 1, D and E, Ca
2+). Thus, Ca
2+-triggered lyso-
somal exocytosis seems necessary for the rapid endocytosis pre-
viously shown to be involved in plasma membrane repair (Idone 
et al., 2008b).
Wounded cells secrete the lysosomal 
enzyme ASM
There is a strong morphological similarity between injury-induced 
endosomes (Idone et al., 2008b) and the large intracellular 
vesicles formed in cells treated with bacterial sphingomyelinase 
(Zha et al., 1998). Because lysosomes contain ASM, an acid-
active form of sphingomyelinase, we investigated whether this 
lysosomal enzyme played a role in the endocytosis-mediated 
plasma membrane repair process. We found that ASM activity 
levels in the culture medium increased markedly when cells were 
permeabilized with SLO in the presence of Ca
2+. Consistent with 
the Ca
2+ requirement for lysosomal exocytosis, an increase in   
secreted ASM activity was not observed when extracellular Ca
2+ 
was replaced by Mg
2+ (Fig. 2). These results show that ASM   
is  released  from  lysosomes  into  the  extracellular  medium 
Figure 2.  Cell injury triggers Ca
2+-dependent secretion of lysosomal ASM. 
ASM activity was assayed in the culture medium of NRK cells 4 min after 
exposure to SLO. An 10-fold increase in secreted ASM activity was ob-
served after exposure to SLO/Ca
2+. The data represent the mean ± SD of 
triplicate determinations. These results are representative of several inde-
pendent experiments.JCB • VOLUME 189 • NUMBER 6 • 2010   1030
Figure 3.  Blocking ASM activity does not inhibit lysosomal exocytosis but impairs endocytosis and plasma membrane repair. (A) ASM activity in NRK cell 
lysates not treated (NT) or treated with DPA (95% inhibition). Error bars represent SEM. SM, sphingomyelin. (B) -Hexosaminidase (Hex) secretion from 
nontreated (NT) or DPA-treated NRK cells after exposure to SLO with or without Ca
2+. Error bars represent SD. (C) Quantification of BSA-gold–containing   
endosomes detected by EM in DPA-treated or nontreated cells 4 min after exposure to SLO/Ca
2+ and BSA-gold. The data represent the mean ± SD   1031 Lysosomal sphingomyelinase mediates cell resealing • Tam et al.
injury (Fig. 7, A and B). Importantly, when rhASM (He et al., 
1999) was added simultaneously with SLO/Ca
2+, it restored the 
ability of NPA cells to reseal their plasma membrane, stopping 
the influx of FM1-43 (Fig. 6, D and E; and Video 3).
Transcriptional silencing of ASM inhibits 
endocytosis and plasma membrane repair, 
a defect reversed by the extracellular 
addition of rhASM
To determine the consequences of acute ASM depletion, we used 
siRNA to transcriptionally silence SMPD1, the gene encoding for 
ASM. A reduction of 85% in ASM expression, determined 
with a specific enzymatic assay for ASM activity, was observed 
in HeLa cells after treatment with an SMPD1 (ASM) siRNA   
duplex (Fig. 8 A). Immunoblot analysis confirmed that SMPD1 
(ASM) reduced expression of the ASM protein (Fig. 8 B). When 
compared with cells treated with control siRNA, EM quantification 
showed that cells treated with ASM siRNA contained a signifi-
cantly reduced number of BSA-gold–containing vesicles 4 min 
after exposure to SLO/Ca
2+ (Fig. 8 C and Fig. S1). Similar to the 
endosomes  formed  after  cell  injury  observed  in  our  previous 
massively stain intracellular compartments (Fig. 3, E and F; and 
Video 1). FACS analysis of cell populations injured in suspension 
with SLO and exposed to PI after 4 min also revealed a DPA- 
dependent  defect  in  plasma  membrane  resealing  (Fig.  4 A).   
A similar defect was observed in cells injured by scraping (Fig. 4 B). 
These findings link the lysosomal enzyme ASM to the induction 
of endocytosis in wounded cells and show that lysosomal exo-
cytosis per se is not sufficient for plasma membrane repair. 
Despite high levels of lysosomal exocytosis after injury, without 
active ASM, cells cannot efficiently endocytose and reseal their 
plasma membrane.
ASM-deficient Niemann-Pick type A  
(NPA) cells are defective in endocytosis 
and plasma membrane repair after 
injury, but resealing is restored by the 
extracellular addition of recombinant 
human ASM (rhASM)
We proceeded to directly examine the consequences of ASM de-
ficiency on lysosomal exocytosis, endocytosis, and plasma mem-
brane repair. NPA disease is a lysosomal storage disorder caused 
by a genetic deficiency in ASM. The lysosomal accumulation of 
sphingomyelin resulting from deficient ASM activity leads to 
serious pathology, including aberrant cholesterol metabolism 
and functional defects in several tissues, particularly the nervous 
system (Schuchman, 2007). Enzymatic activity assays confirmed 
that a lymphoblast cell line derived from an NPA human patient 
contained no detectable ASM when compared with a normal 
human lymphoblast cell line (Fig. 5 A). The large majority of the 
control and NPA human lymphoblasts remained impermeable 
to PI when not exposed to SLO (Fig. 5 B). However, after SLO 
permeabilization in the presence of Ca
2+, a resealing defect that 
increased with the extent of SLO permeabilization was observed 
(Fig. 5 C). Both cell types were equally permeabilized, as as-
sessed by the number of cells containing high levels of PI after 
exposure to SLO under no repair conditions (Fig. 5 C, Mg
2+).
These findings were further investigated using fibroblasts 
from an NPA patient that also lacked detectable ASM activity 
(Fig. 6 A). When compared with fibroblasts from a normal human 
patient, NPA fibroblasts showed enhanced -hexosaminidase se-
cretion after exposure to SLO/Ca
2+ (Fig. 6 B), similar to what was 
observed after ASM inhibition with DPA (Fig. 3 B). In contrast, 
injury-dependent endocytosis (Fig. 6 C) and plasma membrane 
repair (Fig. 6, D and E; and Fig. 7, A and B) were inhibited in 
wounded NPA fibroblasts. Control human fibroblasts efficiently 
resealed their plasma membrane after SLO permeabilization in 
the presence of Ca
2+, effectively blocking the influx of FM1-43 
(Fig. 6, D and E; and Video 2) and PI uptake (Fig. 7, A and B). In 
contrast, NPA fibroblasts were defective in controlling the intra-
cellular flow of FM1-43 (Fig. 6, D and E; and Video 3) and PI after 
(**, P < 0.0001; unpaired Student’s t test). (D) FACS quantification of WGA-FITC endocytosis in nontreated or DPA-treated NRK cells after SLO exposure 
or scraping in Ca
2. (E) Time-lapse imaging of FM1-43 influx into NRK cells exposed or not to SLO in the presence of Ca
2+. FM1-43 influx was contained 
in nontreated cells (black) but not in DPA-treated cells (red; Video 1). Cells not exposed to SLO did not show a significant increase in FM1-43 intracellular 
staining (green and purple). 30–89 cells were analyzed in each condition; error bars correspond to the mean ± SEM. (F) Selected time frames of cells 
treated or not with DPA but not exposed to SLO and of Video 1 (SLO-exposed cells treated or not with DPA in Ca
2+). The results shown in this figure are 
representative of several independent experiments. Bars, 9 µm.
 
Figure 4.  Inhibition of ASM activity impairs restoration of plasma mem-
brane integrity. (A) FACS quantification of PI staining in nontreated or DPA-
treated cells wounded by SLO permeabilization. (B) FACS quantification 
of PI staining in nontreated or DPA-treated cells, mechanically wounded by 
scraping from the dish. Without Ca
2+ (Mg
2+), both groups of cells remained 
permeabilized; with Ca
2+, DPA-treated cells resealed less efficiently than 
nontreated cells. Percentages correspond to resealed (PI negative) cells in 
the gated region (dashed lines). The results shown in this figure are repre-
sentative of several independent experiments.JCB • VOLUME 189 • NUMBER 6 • 2010   1032
that dynamic sorting events occur in these endosomes after   
formation. As observed in NPA and DPA-treated cells, plasma 
membrane repair was also defective in cells subjected to ASM   
silencing (Fig. 8, D and E; and Fig. S2). Time-lapse imaging assays 
showed that RNAi-mediated ASM knockdown reduced the effi-
ciency by which cells controlled the influx of FM1-43 after SLO 
permeabilization in the presence of Ca
2+ when compared with 
cells treated with control siRNA (Fig. 8, D and E; and Video 4). 
As observed with NPA patient cells (Fig. 5 C), FACS-based pop-
ulation assays showed that the defect in plasma membrane repair 
resulting from siRNA-mediated ASM silencing increased with 
the extent of cell permeabilization (Fig. S2). The addition of 
rhASM to the culture medium during SLO permeabilization 
restored endocytosis (Fig. 8 C) and plasma membrane repair, as 
indicated by an increased ability of cells to stop the influx of 
FM1-43 (Fig. 8, D and E) or PI (Fig. S2). Collectively with the 
rescue of plasma membrane repair in SLO-treated NPA fibro-
blasts by rhASM (Fig. 6 D and Video 3), these results establish a 
solid link between extracellular ASM activity and the ability of 
cells to remove pores from their plasma membrane.
Discussion
In this study, we investigated the relationship between Ca
2+-
triggered exocytosis of lysosomes and the rapid endocytosis 
that occurs after plasma membrane injury. Earlier studies estab-
lished a functional link between lysosomal exocytosis and 
plasma membrane repair (Reddy et al., 2001; Chakrabarti et al., 
2003; McNeil and Steinhardt, 2003), but the precise membrane-
resealing mechanism remained elusive. Wound patching by 
endomembranes delivered to the cell surface by exocytosis was 
initially thought to be the event responsible for plasma mem-
brane repair (McNeil and Steinhardt, 2003; McNeil et al., 2003). 
However, a recent study changed this view by showing that 
plasma membrane lesions can be internalized through a Ca
2+-
dependent, rapid form of endocytosis (Idone et al., 2008b). By 
further investigating this pathway, we found that the lysosomal 
enzyme ASM is released extracellularly during cell injury and 
participates in the process of endosome formation and plasma 
membrane repair.
Generation of ceramide on lipid bilayers through the hydro-
lytic removal of the phosphorylcholine head group of sphingo-
myelin by sphingomyelinase is known to promote inward bending 
and budding of membranes (Gulbins and Kolesnick, 2003; van 
Blitterswijk et al., 2003; Grassmé et al., 2007). The membrane-
bending properties of sphingomyelinase-generated ceramide 
were also directly demonstrated in experiments using liposomes 
(Holopainen et al., 2000) and implicated in important physiologi-
cal events such as intraluminal budding in multivesicular endo-
somes (Trajkovic et al., 2008). Interestingly, in the case of 
intraluminal budding in multivesicular endosomes, the enzyme 
implicated was neutral sphingomyelinase 2, which is found in the 
cytosol (Trajkovic et al., 2008). This is consistent with the opposite 
topology of luminal budding into multivesicular bodies and endo-
some formation, which requires exposure of the outer leaflet   
of the plasma membrane to an extracellular sphingomyelinase.   
In this study, we provide experimental evidence supporting the 
study (Idone et al., 2008b), these vesicles were large and mostly 
uncoated. Interestingly, in some of these vesicles, areas of local-
ized coat deposition could be detected (Fig. S1 A, top), suggesting 
Figure  5.  ASM-deficient  NPA  lymphoblasts  show  a  defect  in  plasma 
membrane repair that is proportional to the extent of cell permeabiliza-
tion. (A) ASM activity in lysates of lymphoblasts derived from a normal 
human control (NC) or an NPA human patient. NPA cells lacked detect-
able ASM activity. The error bar represents SEM. SM, sphingomyelin.   
(B) FACS quantification of PI staining in lymphoblasts derived from a nor-
mal control or NPA patient. When not exposed to SLO, most cells were 
impermeable to PI. (C) FACS quantification of PI staining in lymphoblasts 
derived from a normal control (black) or NPA patient (red) after exposure 
to SLO. NPA lymphoblasts were defective in plasma membrane resealing 
when compared with normal lymphoblasts. Without Ca
2+, both groups of 
cells remained permeabilized (left); with Ca
2+, control cells resealed more 
efficiently (right). (B and C) Percentages correspond to resealed (PI nega-
tive) cells in the gated region (dashed lines). The results shown in this figure 
are representative of several independent experiments.1033 Lysosomal sphingomyelinase mediates cell resealing • Tam et al.
Figure 6.  ASM-deficient NPA fibroblasts are defective in injury-dependent endocytosis and plasma membrane repair. (A) ASM activity in lysates of normal 
human fibroblasts (NC) or NPA human fibroblasts. Error bars represent SEM. The inset shows an immunoblot of normal human or NPA fibroblasts using 
anti-ASM antibodies. The 75-kD band corresponding to ASM (arrow) was undetectable in NPA cells; the higher additional band is an unspecific reac-
tion. SM, sphingomyelin. (B) -Hexosaminidase (Hex) secretion from normal human or NPA cells after exposure to SLO with or without Ca
2+. Error bars 
represent SD. (C) FACS quantification of endocytosis after scrape wounding in normal human or NPA cells. (D) Time-lapse imaging of FM1-43 influx into 
cells exposed or not to SLO in the presence of Ca
2+. FM1-43 influx was contained in normal human cells (Video 2) but not in NPA cells. The addition of 
rhASM at the time of SLO permeabilization restores the capacity of NPA cells to stop FM1-43 influx (Video 3). Non–SLO-permeabilized cells did not show 
a significant increase in FM1-43 intracellular staining (purple). 4–11 cells were analyzed in each condition; error bars correspond to the mean ± SEM.   
(E) Selected time frames of Videos 2 and 3. The results shown in this figure are representative of several independent experiments. Bars, 9 µm.JCB • VOLUME 189 • NUMBER 6 • 2010   1034
with a potential role for ASM in maintaining the integrity of cells 
subjected to mechanical stress, abnormalities in the permeability 
barrier properties of skin were reported in a subset of Niemann-
Pick patients (Schmuth et al., 2000), and reduced ASM activity 
levels were detected in patients with atopic dermatitis (Jensen   
et al., 2004).
One of the main morphological features of NPA cells is the 
large accumulation of sphingomyelin and cholesterol observed 
within lysosomes, as a consequence of ASM deficiency. For this 
reason, the disease was traditionally viewed as a lysosomal stor-
age disorder. However, it has become increasingly evident that 
another major physiological role of ASM is to initiate ceramide-
driven signaling cascades at the cell surface. Extracellular delivery 
of ASM places this enzyme in direct contact with sphingomyelin, 
one of the most abundant lipids in the outer layer of the plasma 
membrane. There is extensive evidence that ASM-mediated hydro-
lytic removal of the phosphorylcholine head group of sphingo-
myelin generates extracellularly oriented ceramide platforms 
on the plasma membrane (Grassmé et al., 2003; Gulbins, 2003; 
Schuchman, 2010). Several studies detected ASM on the cell sur-
face after exposure to stress signals such as irradiation, heat 
shock, UV light exposure, or bacterial infection, but the mecha-
nism by which this lysosomal enzyme was released extracellu-
larly has remained obscure (Grassmé et al., 2003; Gulbins, 2003; 
Schuchman, 2010). Consistent with these observations, cells de-
rived from Niemann-Pick patients or from ASM knockout mice 
conclusion that ASM, the acidic sphingomyelinase resident in 
lysosomes, can be exocytosed from injured cells and act on the 
outer plasma membrane to promote endocytosis.
Our results show that inhibition of ASM release from lyso-
somes, ASM genetic deficiency, or inhibition/depletion of ASM 
activity each impair the ability of cells to undergo endocytosis in 
response to injury and to efficiently reseal their plasma mem-
brane. Furthermore, endocytosis and plasma membrane repair 
can be restored in ASM-deficient cells by the exogenous addition 
of the recombinant enzyme. Given that injury-dependent endo-
cytosis and plasma membrane repair occur within a few seconds 
of membrane wounding (Steinhardt et al., 1994; Idone et al., 
2008b), our findings clearly implicate immediate, local effects of 
ASM-generated ceramide in the outer leaflet of the plasma mem-
brane, as opposed to slower, downstream signaling effects.
Recessive mutations in the ASM-encoding gene (SMPD1) 
are responsible for the human genetic diseases NPA and NPB. 
NPA patients develop a rapidly progressing neurodegeneration 
that leads to death in the first 2–3 yr of life. NPB is a milder dis-
ease form associated with residual ASM activity (Schuchman, 
2007). We found that lymphoblasts and fibroblasts derived from 
NPA patients have defects in injury-dependent endocytosis and 
plasma membrane repair that can be rescued by exogenously 
added ASM. Thus, our observations raise the possibility that de-
fective repair of wounded plasma membrane contributes to the 
severe pathology that develops in NPA patients. In agreement 
Figure 7.  NPA fibroblasts are deficient in plasma membrane resealing after SLO wounding. (A) FACS quantification of PI staining in normal control or NPA 
fibroblasts after SLO permeabilization. Without Ca
2+ (Mg
2+; middle), both groups of cells remained permeabilized; with Ca
2+, normal fibroblasts resealed 
more efficiently (right). Percentages correspond to resealed (PI negative) cells in the gated region (dashed lines). (B) Images of PI-stained normal or NPA 
fibroblasts permeabilized by SLO. NPA fibroblasts showed increased levels of PI staining after wounding in the presence of Ca
2+ when compared with 
normal control fibroblasts. The results shown in this figure are representative of several independent experiments. Bars, 20 µm.1035 Lysosomal sphingomyelinase mediates cell resealing • Tam et al.
membrane wounds is a major event promoting ASM secretion by 
triggering the fusion of lysosomal compartments with the plasma 
membrane. In agreement with this view, we found that ASM 
activity is not released from cells wounded in the absence of 
extracellular Ca
2+, a condition which does not allow lysosomal 
exocytosis (Rodríguez et al., 1997; Reddy et al., 2001).
(which  also  develop  a  severe  neurodegenerative  disease; 
Horinouchi et al., 1995) are resistant to radiation-induced apop-
tosis, a defect attributed to disruption of ceramide-mediated 
signaling cascades normally initiated at the outer leaflet of the 
plasma membrane (Santana et al., 1996; Schuchman, 2010). Our 
present results strongly suggest that Ca
2+ influx through plasma 
Figure  8.  The  defects  in  endocytosis  and 
plasma  membrane  repair  observed  after  si-
lencing of ASM expression are rescued by ex-
ogenous rhASM. (A) ASM activity in lysates of 
HeLa cells treated with control or ASM siRNA. 
Error  bars  represent  SEM.  SM,  sphingomy-
elin. (B) Immunoblots with anti-ASM (top) or 
antiactin antibodies (bottom) of HeLa cells not 
treated or treated with control or ASM siRNA. 
The arrow points to the 75-kD band corre-
sponding to ASM. The higher additional band 
is an unspecific reaction. (C) Quantification of 
BSA-gold–containing endosomes detected by 
EM in HeLa cells 4 min after exposure to SLO/
Ca
2+ and BSA-gold. The cells were pretreated 
with  control  siRNA,  ASM  siRNA,  or  ASM 
siRNA followed by rhASM added during the 
SLO wounding procedure. The data represent 
the mean ± SD (**, P < 0.0001; comparing 
control  or  ASM  +  rhASM  with  ASM  by  un-
paired Student’s t test). (D) Time-lapse imaging 
of FM1-43 influx into HeLa cells exposed or 
not to SLO in the presence of Ca
2+. FM1-43 
influx was contained in cells treated with con-
trol siRNA but not in cells treated with ASM 
siRNA. The addition of rhASM at the time of 
SLO  permeabilization  restored  the  capacity 
of NPA cells to stop FM1-43 influx (Video 2). 
Non–SLO-permeabilized  cells  did  not  show 
a significant increase in FM1-43 intracellular 
staining (green and purple). 37–63 cells were 
analyzed in each condition; error bars corre-
spond to the mean ± SEM. (E) Selected time 
frames of Video 4. Bars, 9 µm.JCB • VOLUME 189 • NUMBER 6 • 2010   1036
(Inada et al., 2000), calpain (Godell et al., 1997; Mellgren et al., 
2007), and mitsugumin 53 (Weisleder et al., 2009) also play a 
role in cell resealing. However, inhibition of lysosomal exo-
cytosis by a variety of approaches can prevent resealing in the 
majority of wounded cell populations (Fig. 1; Reddy et al., 2001), 
indicating that exocytosis of this organelle plays a central role in 
plasma membrane repair. Interestingly, there is evidence that 
extracellularly released lysosomal enzymes can activate cytosolic 
proteins involved in wound repair (Egberts et al., 2004). Future 
studies should clarify whether additional lysosomal hydrolases 
delivered to the cell surface by exocytosis participate in the acti-
vation of ASM and/or other steps of the pathway leading to resto-
ration of plasma membrane integrity.
Materials and methods
Cells
NRK and HeLa CCL-2.1 (HeLa 229) cells were cultured at 37°C in 5% CO2 
in high glucose DME 10% heat-inactivated FBS containing penicillin/
streptomycin (Invitrogen). Normal human fibroblasts (#CRL2522; Ameri-
can Type Culture Collection) and NPA fibroblasts (#GM00112; Coriell) were 
cultured in DME 20% noninactivated FBS supplemented with 1× MEM 
nonessential amino acids and 1× vitamin solution containing penicillin/
streptomycin (Invitrogen). The human lymphoblast lines MS609AT (normal 
human patient) and MS2059CK (NPA patient) were from the Schuchman 
Laboratory and grown in RPMI 1640 10% heat-inactivated FBS containing 
penicillin/streptomycin (Invitrogen).
Drug treatments
Cells were treated with 50 µM BEL (Sigma-Aldrich) for 30 min or with   
30 µM DPA (Sigma-Aldrich) for 60 min before experiments.
ASM transcriptional silencing and complementation with rhASM
HeLa cells (50% confluency) in 35-mm wells containing 250 µl Opti-MEM I 
reduced serum were transfected with Lipofectamine and 160 pmol of 
medium  GC  content  control  (12935300)  or  SMPD1  (HSS143988, 
[RNA]ﾭ5-GCCCUGCCGUCUGGCUACUCUUUGU-3)  Stealth  siRNA  du-
plexes, according to manufacturer’s instructions (Invitrogen). At 55 h after 
We found that ASM inhibition or genetic deficiency does not 
impair the exocytosis of the lysosomal enzyme -hexosaminidase, 
indicating that lysosomal exocytosis in itself is not sufficient 
for plasma membrane repair. This finding led us to propose a new 
model for plasma membrane repair, in which the release of lyso-
somal contents (as opposed to the delivery of lysosomal mem-
branes) would represent the major event leading to membrane 
resealing. Our findings are consistent with the following mecha-
nism: Ca
2+ influx through membrane lesions triggers exocytosis 
of lysosomes and extracellular release of ASM, which in turn 
converts sphingomyelin to ceramide in the outer leaflet of the 
plasma membrane, leading to endosome formation (Holopainen 
et al., 2000; Gulbins and Kolesnick, 2003) and lesion removal 
(Fig. 9; Idone et al., 2008b). This model provides for the first time 
a molecular mechanism by which lysosomal exocytosis can pro-
mote endocytosis and plasma membrane repair.
Despite its optimal activity at acidic pH, our reconstitution 
experiments show that rhASM can act extracellularly, promoting 
endocytosis and plasma membrane repair under physiological con-
ditions. These findings are consistent with earlier studies showing 
that ASM has sufficient activity at neutral pH to hydrolyze 
sphingomyelin within low density lipoprotein particles (Schissel 
et al., 1998) and to initiate signaling cascades in the outer leaflet 
of the plasma membrane (Grassmé et al., 2003; Gulbins, 2003). 
Mechanisms promoting ASM activity in the extracellular environ-
ment may include acidic microenvironments generated at the cell 
surface during lysosomal exocytosis (Baron et al., 1985) or en-
zyme activation by lysosomal lipids such as lysobisphosphatidic 
acid (Linke et al., 2001).
Collectively, our results suggest that ASM-dependent endo-
cytosis is a major component of the plasma membrane repair pro-
cess driven by Ca
2+ influx. Earlier studies have suggested that 
Ca
2+-dependent cytosolic proteins such as transglutaminase-1 
Figure 9.  Model for plasma membrane repair mediated by secreted lysosomal ASM. Extracellular Ca
2+ flows into cells through plasma membrane wounds 
(the diagram shows in red pores formed by insertion of the bacterial toxin SLO). Elevation in the intracellular Ca
2+ concentration triggers exocytosis of lyso-
somes. Lysosomal ASM is delivered to the outer leaflet of the plasma membrane, where it converts sphingomyelin into ceramide. Ceramide self-associates 
into microdomains that bud into the cells, generating endosomes that internalize the lesions and reseal the plasma membrane.1037 Lysosomal sphingomyelinase mediates cell resealing • Tam et al.
(52 mCi/mmol; PerkinElmer) was resuspended in 20 µl of 100 mM sodium 
acetate, pH 5.0, and 100 µM ZnCl2 containing 2.7% Triton X-100 and 
vortexed. The assay solution consisted of 50 µl of assay buffer, 20 µl of 
substrate, and 20 µl of cell extract. After incubation for 60 min at 37°C, 
the reaction was terminated by adding 125 µl chloroform/methanol 
(2:1, vol/vol). Tubes were vortexed and centrifuged at 5,000 g for 5 min at 
4°C, and 50 µl of the upper aqueous phase was removed for determination 
of the amount of [
14C]ﾭphosphorylcholine released from [
14C]ﾭsphingomyelin 
by scintillation counting. Samples were normalized for protein concentration 
using a BCA Protein assay kit (Thermo Fisher Scientific). The ASM activity se-
creted during cell wounding was measured in a similar manner, except that 
conditioned medium (from the supernatant of cells after 4 min of SLO treat-
ment at 37°C) was collected and concentrated using Amicon Centriprep 
YM-10 (Millipore). Secreted ASM activity was expressed as a percentage of 
the total activity present in cell lysates. Western blotting for ASM was per-
formed on cell lysates separated by SDS-PAGE, transferred to nitrocellulose, 
and incubated with affinity-purified anti-ASM rabbit antibodies (provided by 
R. Jenkins and Y. Hannun, Medical University of South Carolina, Charleston, 
SC) prepared as described previously (Zeidan and Hannun, 2007).
Online supplemental material
Fig. S1 shows that large BSA-gold–positive endosomes are detected in 
HeLa cells transfected with different siRNA duplex oligonucleotides and in-
jured with SLO. Fig. S2 shows that transcriptional silencing of ASM causes 
a defect in plasma membrane repair that is proportional to the extent of 
cell permeabilization and is reversed by the addition of rhASM. Video 1 
shows that inhibition of ASM activity with DPA allows rapid and sustained 
FM1-43 influx into SLO-permeabilized NRK cells. Video 2 shows that nor-
mal human fibroblasts control FM1-43 influx after SLO permeabilization. 
Video 3 shows that NPA fibroblasts are deficient in controlling FM1-43 in-
flux after SLO permeabilization but that the addition of rhASM restores 
their ability to reseal their plasma membrane. Video 4 shows that HeLa 
cells treated with ASM siRNA are deficient in controlling FM1-43 influx   
after SLO permeabilization, a defect which is rescued with the exogenous 
addition of rhASM. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.201003053/DC1.
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